Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chung-Che Chang

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
Molecular Cancer Therapeutics|November 11, 2010
Luteinizing Hormone-Releasing Hormone (LHRH)-I antagonist cetrorelix inhibits myeloma cell growth in vitro and in vivoJianguo Wen, Yongdong Feng, Chad C Bjorklund, et al.
The Journal of Molecular Diagnostics : JMD|August 21, 2010
Array comparative genomic hybridization detects chromosomal abnormalities in hematological cancers that are not detected by conventional cytogeneticsLina Shao, Sung-Hae L Kang, Jian Li, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 24, 2007
The role of Janus Kinase 2 V617F mutation in extramedullary hematopoiesis of the spleen in neoplastic myeloid disordersPin-Pen Hsieh, Randy J Olsen, Dennis P O'Malley, et al.
American Journal of Clinical Pathology|September 19, 2007
EBV viral load in tumor tissue is an important prognostic indicator for nasal NK/T-cell lymphomaPin-Pen Hsieh, Chun-Liang Tung, Amy Bik-Wan Chan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 4, 2004
Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profilesFrancisco Vega, Chung-Che Chang, Leonard J Medeiros, et al.
Clinical Lung Cancer|August 19, 2020
Prognostic Value of KRAS Mutation Subtypes and PD-L1 Expression in Patients With Lung AdenocarcinomaLuwei Tao, Ruoyu Miao, Tarek Mekhail, et al.
Leukemia Research|December 17, 2008
Multiple distinct clones may co-exist in different lineages in myelodysplastic syndromesWan-Ting Huang, Xiaorong Yang, Xiaobo Zhou, et al.
Pediatric Blood & Cancer|May 18, 2019
A clinicopathologic study of the spectrum of systemic forms of EBV-associated T-cell lymphoproliferative disorders of childhood: A single tertiary care pediatric institution experience in North AmericaAmy M Coffey, Annisa Lewis, Andrea N Marcogliese, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 2, 2022
Mast cell sarcoma: clinicopathologic and molecular analysis of 10 new cases and review of literatureNana P Matsumoto, Ji Yuan, Jun Wang, et al.
Life Sciences|December 17, 2009
Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa BBor-Sheng Ko, Tzu-Ching Chang, Chien-Hung Chen, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
Molecular Cancer Therapeutics|November 11, 2010
Luteinizing Hormone-Releasing Hormone (LHRH)-I antagonist cetrorelix inhibits myeloma cell growth in vitro and in vivoJianguo Wen, Yongdong Feng, Chad C Bjorklund, et al.
The Journal of Molecular Diagnostics : JMD|August 21, 2010
Array comparative genomic hybridization detects chromosomal abnormalities in hematological cancers that are not detected by conventional cytogeneticsLina Shao, Sung-Hae L Kang, Jian Li, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 24, 2007
The role of Janus Kinase 2 V617F mutation in extramedullary hematopoiesis of the spleen in neoplastic myeloid disordersPin-Pen Hsieh, Randy J Olsen, Dennis P O'Malley, et al.
American Journal of Clinical Pathology|September 19, 2007
EBV viral load in tumor tissue is an important prognostic indicator for nasal NK/T-cell lymphomaPin-Pen Hsieh, Chun-Liang Tung, Amy Bik-Wan Chan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 4, 2004
Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profilesFrancisco Vega, Chung-Che Chang, Leonard J Medeiros, et al.
Clinical Lung Cancer|August 19, 2020
Prognostic Value of KRAS Mutation Subtypes and PD-L1 Expression in Patients With Lung AdenocarcinomaLuwei Tao, Ruoyu Miao, Tarek Mekhail, et al.
Leukemia Research|December 17, 2008
Multiple distinct clones may co-exist in different lineages in myelodysplastic syndromesWan-Ting Huang, Xiaorong Yang, Xiaobo Zhou, et al.
Pediatric Blood & Cancer|May 18, 2019
A clinicopathologic study of the spectrum of systemic forms of EBV-associated T-cell lymphoproliferative disorders of childhood: A single tertiary care pediatric institution experience in North AmericaAmy M Coffey, Annisa Lewis, Andrea N Marcogliese, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 2, 2022
Mast cell sarcoma: clinicopathologic and molecular analysis of 10 new cases and review of literatureNana P Matsumoto, Ji Yuan, Jun Wang, et al.
Life Sciences|December 17, 2009
Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa BBor-Sheng Ko, Tzu-Ching Chang, Chien-Hung Chen, et al.
Pageof 11